Infrastructure Construction in Africa, Forecast, and Opportunity Assessment 2021


Infrastructure Construction in Africa
Synopsis
Infrastructure construction in Africa is expected to grow rapidly in the coming years, reaching around US$196 billion in 2021, up from US$126 billion in 2016, expanding at an annual average rate of over 9% in nominal US$ terms.
Timetric’s Infrastructure Intelligence Center is currently tracking 1,377 large-scale infrastructure projects in Africa in both the public and private sectors. Collectively these projects are worth US$1.3 trillion, including projects at all stages of development from announcement to execution.
Click here for sample report @http://www.wiseguyreports.com/sample-request/2685357-infrastructure-construction-in-africa-to-2021
Summary
The report provides an overview of the infrastructure construction sector in Africa, including key trends and factors driving infrastructure investment.
The report covers analysis of the project pipelines, with details on all major projects, sectoral spread, project ownership, funding mechanisms and main contractors.
Scope
A concise analysis of the economic context for infrastructure in Africa.
Five-year forecasts of infrastructure construction output for each region.
An analysis of the project pipelines, with details on all major projects, funding mechanisms, project ownership, and main contractors.
Reasons To Buy
• Assess the main drivers of infrastructure investment in Africa, including the political and operating landscape and financing methods.
• Analyze forecasts and understand key infrastructure trends at regional and continental level.
• Gain insight into which construction companies are most heavily involved in the Africa infrastructure sector.
• Identify all major projects by value, start date, stage of development to inform your expansion strategy.
Key Highlights
With 366 projects valued at US$391.7 billion, West Africa is home to the largest infrastructure construction project pipeline in Africa.
West Africa also has the highest number of projects in the continent, ahead of Southern Africa with 341. Southern Africa’s pipeline value stands at US$305 billion. East Africa also has a large number of projects – 318 in total – but its pipeline value amounts to US$164 billion.
North Africa has a total of 267 projects, and has the second-largest value of projects in the continent at US$341.4 billion. The lowest number of projects is found in Central Africa with only 85 projects, valuing US$60.6 billion.
In terms of single country project pipelines, Nigeria has the largest share of projects in Africa with a combined value of US$216.6 billion. This is followed by Egypt with a pipeline value of US$155.5 billion and South Africa with a pipeline value of US$118.8 billion.
The electricity and power sector has the highest concentration of infrastructure projects in the pipeline with 659 projects, followed by roads (256), airports and other infrastructure (252), railways (135), water and sewerage (65) and telecommunications (10).
In terms of US dollar value, electricity and power projects also dominate valued at US$622.2 billion while railways valued at US$342.3 account for the second-largest sector.
Airports and other infrastructure recorded the third-largest share with US$188.7 billion, followed by roads which make up US$125.3 billion, water and sewerage which accounts for US$15.8 billion and telecommunications with US$1.3 billion.
Table of Contents                                          

1. EXECUTIVE SUMMARY
2. AFRICA ECONOMIC OVERVIEW
3. INFRASTRUCTURE INVESTMENT IN AFRICA
    3.1. Key Investment Trends
    3.2. Factors Driving Investment
      3.2.1. Demographics
      3.2.2. Political and Operating Landscape
      3.2.3. Infrastructure Financing
      3.2.4. Infrastructure Gaps
    3.3. Africa: Infrastructure Project Pipeline
4. NORTH AFRICA
    4.1. North Africa: Overview
    4.2. North Africa: Infrastructure Project Pipeline
    4.3. Country Focus: Egypt
      4.3.1. Egypt’s infrastructure project pipeline
    4.4. Country Focus: Morocco
      4.4.1. Morocco’s infrastructure project pipeline 
For Detailed Reading Please visit @https://www.wiseguyreports.com/reports/2685357-infrastructure-construction-in-africa-to-2021
About Us                                                                           
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Comments

Post a Comment

Popular posts from this blog

Hypotension Treatment Market 2018 – 2023 Projected to Grow Radiantly by Top Players Revenue and Growth Rate

Market Overview: Hypotension refers to very low blood pressure and affects people across all age groups. Blood pressure is the force exerted by human blood against the artery walls, while blood is pumped out by the heart. Hypotension is normally characterized by a diastolic pressure that is lower than 60mm Hg. A systolic pressure lower than 90 mm Hg is also typically symptomatic of hypotension. The global hypotension market is propelled by hypotension incidences, diabetes, cardiovascular disorders, and other health issues. When patients suffer from low blood pressure or hypotension, they may feel dizziness while standing up after sitting for long periods of time. This is why, many of them are advised to not rise suddenly and take support/more time to stand up without any discomfort. Hypotension can also result from dehydration, nervous disorders, and endocrine issues. The geriatric population is quite susceptible to suffering from low blood pressure, boosting the rates of hosp...
Read more

Hemostasis and Tissue Sealing Agents Market Forecasts by Industry Drivers, Regions Till 2030

  Market Highlights The global  hemostasis and tissue sealing agents market size  is projected to grow at a CAGR of 8.6% over the forecast period. There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Increasing numbers of surgery procedures worldwide is one of another reason for driving the growth of the hemostasis and tissue sealing agents market.  Surgeries are performed by making cut on the body which leads to the wound formation. Hemostasis and tissue sealing agents products are used in external surgical processes for reducing bleeding. For example, they are used in neurosurgical procedures, cardiac surgery, bariatric surgery, leg surgery, cesarean and orthopedic surgery. Hemostasis and tissue sealing agents products, are frequently used to reduce complexity and reduce recovery time after surgery. T...
Read more

Stem Cell Manufacturing Market Professional Overview 2022-2030 with Major Vendors Size, Shares and Worldwide Demand

  Stem Cell Manufacturing Market - Highlights The Stem Cell Manufacturing Industry is expected to have accounted for the market value of USD 10.8 billion in 2022 and is projected to grow at a Stem Cell Manufacturing Market CAGR of 6.6% over the assessment period. Stem cell manufacturing is a process in which cells from the bone marrow or peripheral blood cells are isolated and cultured in a culture dish containing nutrient media. Rising stem cell related transplants, increasing number of clinical trials for stem cell therapies and growing stem cell research is anticipated to boost the growth of the market during the assessment period. According to a report published by Lozier Institute in November 2022, there are nearly 3,500 ongoing or completed clinical trials (in patients) using adult stem cells, as listed in the National Institutes of Health/FDA-approved database. On the other hand, high costs associated with stem cell research and stringent govern...
Read more